Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer
Status:
Completed
Trial end date:
2011-04-26
Target enrollment:
Participant gender:
Summary
The addition of chemotherapy to radiotherapy (chemoradiation) has improved outcomes for
patients with locally advanced squamous cell carcinoma of the head and neck but additional
improvements to treatment regimens are needed. The study is investigating if the addition of
a targeted therapy (panitumumab) can improve the efficacy of chemoradiation without adding
unmanageable toxicity.